Get started
Award

P20_00442

Funded outputs count: 10
Funder award ID: P20_00442
OpenAlex ID: G516119758
Intermittent time-restricted feeding recapitulates the physiological benefits of daily time-restricted feeding in male mice with chronic metabolic disease
2026 · Andre Sarmento-Cabral, Marta G. Novelle, et al. · Molecular Metabolism
PDF
The telomerase/shelterin system is impaired in acromegaly and Cushing´s disease: Potential pathophysiological relevance
2026 · Miguel E. G-García, Ana S. De la Rosa-Herencia, et al. · Biomedicine & Pharmacotherapy
Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets
2025 · Antonio C. Fuentes-Fayos, Miguel E. G-García, et al. · Acta Neuropathologica Communications · 2
PDF
Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma
2025 · Miguel E. G-García, Ana S. De la Rosa-Herencia, et al. · Cellular and Molecular Life Sciences · 4
PDF
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study
2024 · Miguel Sampedro-Nuñez, Aura Dulcinea Herrera-Martínez, et al. · European Journal of Endocrinology · 8
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
2023 · Antonio C. Fuentes-Fayos, Miguel E. G-García, et al. · EBioMedicine · 47
PDF
Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin
2022 · Prudencio Sáez-Martínez, Francisco Porcel-Pastrana, et al. · International Journal of Molecular Sciences · 9
Integrative Clinical, Radiological, and Molecular Analysis for Predicting Remission and Recurrence of Cushing Disease
2022 · Paloma Moreno-Moreno, Alejandro Ibáñez-Costa, et al. · The Journal of Clinical Endocrinology & Metabolism · 8
PDF
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
2022 · Vicente Herrero-Aguayo, Prudencio Sáez-Martínez, et al. · Molecular Therapy — Nucleic Acids · 12
Epigenetic and post‐transcriptional regulation of somatostatin receptor subtype 5 (SST 5 ) in pituitary and pancreatic neuroendocrine tumors
2021 · Sergio Pedraza‐Arevalo, Alejandro Ibáñez‐Costa, et al. · Molecular Oncology · 15
PDF
Year
Topic